SCHEMBL11973098

SCHEMBL11973098

CCCCCCC=C(C)C(C)CC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EP300 Q09472 1/20 0.45
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
CYP3A4 P08684 1/20 0.40
TSHR P16473 2/20 0.39
PTPN1 P18031 2/20 0.36
FAAH O00519 3/20 0.35
TRPV1 Q8NER1 1/20 0.35
TERT O14746 3/20 0.35
MAPT P10636 2/20 0.35
BLM P54132 2/20 0.35
HSD17B10 Q99714 2/20 0.35
FABP4 P15090 2/20 0.35
GMNN O75496 1/20 0.35
USP2 O75604 1/20 0.35
LMNA P02545 1/20 0.35
CYP1A2 P05177 1/20 0.35
POLB P06746 1/20 0.35
CYP2C9 P11712 1/20 0.35
ALOX15 P16050 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11973094 1.00 EP300 (0.45) EP300KMT2AMEN1CYP3A4TSHR
SCHEMBL11973490 0.98 EP300 (0.42) EP300KMT2AMEN1CYP3A4TSHR
SCHEMBL11973489 0.98 EP300 (0.42) EP300KMT2AMEN1CYP3A4TSHR
SCHEMBL10342856 0.85 CA1 (0.45) EP300KMT2AMEN1CYP3A4TSHR
SCHEMBL11973124 0.84 EP300 (0.47) EP300KMT2AMEN1CYP3A4TSHR
SCHEMBL11973141 0.84 EP300 (0.47) EP300KMT2AMEN1CYP3A4TSHR
SCHEMBL11973145 0.84 EP300 (0.47) EP300KMT2AMEN1CYP3A4TSHR
SCHEMBL11973121 0.84 EP300 (0.47) EP300KMT2AMEN1CYP3A4TSHR
SCHEMBL11556336 0.84 GRIK1 (0.31) TSHR
SCHEMBL11973439 0.82 EP300 (0.43) EP300KMT2AMEN1CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2678410-B1 COMPOSIITONS COMPRISING MIXTURES OF C10-C13 ALKYLPHENYL SULFONATES PROCTER & GAMBLE (US) 2017-09-13 EP disclosed
US-9193937-B2 Mixtures of C10-C13 alkylphenyl sulfonates THE PROCTER & GAMBLE COMPANY (US) 2015-11-24 US disclosed
WO-2012138423-A1 COMPOSITIONS COMPRISING MIXTURES OF C10-C13 ALKYLPHENYL SULFONATES THE PROCTER & GAMBLE COMPANY (US) 2012-10-11 WO disclosed
US-20120214724-A1 Mixtures OF C10-C13 Alkylphenyl Sulfonates THE PROCTER & GAMBLE COMPANY 2012-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120214724-A1 Mixtures OF C10-C13 Alkylphenyl Sulfonates SMURF1, C1S, SMURF2 EP300 121/4885KMT2A 2595/4885MEN1 2731/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.